Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 3 2Phase 4 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Disease 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × fluorocholine × Clear all
NCT04965454 2025-05-01

ExTRACT-HCC

Queen's Medical Center

Phase 2 Recruiting
80 enrolled
Gastrointestinal

Disease, Carcinoma, Hepatocellular

NCT02397408 2020-11-19

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

University of California, San Francisco

Phase 2 Completed
18 enrolled 21 charts
Genitourinary

Prostatic Neoplasms

NCT01395030 2018-09-26

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Queen's Medical Center

Phase 2 Completed
64 enrolled 13 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡